Learn how to create burndown charts to track project progress, improve team performance, and download free templates to get ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Dec 3 (Reuters) - Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial intelligence to accelerate the development and testing of small ...

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

As drug developers face increasing pressure to lower prices and accelerate time to market, global biopharmaceutical contract development and manufacturing organization AGC Biologics is expanding its ...

In March 2019, Valve surprised the VR industry with the tease of ‘Index’, its first self-made VR headset. Index would go on to launch later in May 2019 and be seen as the enthusiasts’ choice in PC VR ...

New approach methodologies (NAMs) aim to streamline early-stage drug discovery and revolutionize preclinical testing by replacing traditional animal-based models with human-relevant insights, directly ...

The approach oil majors apply to their exploration activity has evolved significantly in recent years, as operators focus on speed to progress discovery and development and compress the timeline to ...

Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Olathe Gateway gets a new name ...

Even as the pressure to innovate grows, many companies are finding it harder and more expensive to bring new ideas to life. This slowdown is often attributed to rising R&D costs, longer development ...